Last update 09 May 2026

RF-A089

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
RF A089
Target
ALK
Action
inhibitors
Mechanism
ALK inhibitors(Anaplastic lymphoma kinase inhibitors)
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
Non-Small Cell Lung CancerALK positive Non-Small Cell Lung Cancer
Inactive Indication-
Originator Organization
Hubei Bio-Pharmaceutical Industrial Technological InstituteHubei Bio-Pharmaceutical Industrial Technological Institute
Active Organization
Humanwell Healthcare (Group) Co., Ltd.Humanwell Healthcare (Group) Co., Ltd.Hubei Bio-Pharmaceutical Industrial Technological InstituteHubei Bio-Pharmaceutical Industrial Technological Institute
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationSpecial Review Project (China)
Login to view timeline

Related

2
Clinical Trials associated with RF-A089
CTR20181787
/ RecruitingPhase 1
RF-A089口服治疗ALK阳性或ROS1阳性晚期非小细胞肺癌患者安全性及药代动力学的多中心、开放、剂量递增/扩展的I期临床研究
[Translation] A multicenter, open-label, dose-escalation/expansion phase I clinical study on the safety and pharmacokinetics of oral RF-A089 in patients with ALK-positive or ROS1-positive advanced non-small cell lung cancer
ChiCTR1800018660
/ RecruitingPhase 1IIT
A phase I trial to Evaluate the Tolerability, Safety and Pharmacokinetics of RF-A089 in patients With Advanced ALK-Positive or ROS1-Positive Non-Small Cell Lung Cancer (NSCLC)
100 Clinical Results associated with RF-A089
Login to view more data
100 Translational Medicine associated with RF-A089
Login to view more data
100 Patents (Medical) associated with RF-A089
Login to view more data
100 Deals associated with RF-A089
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Small Cell Lung CancerPhase 1
China
Humanwell Healthcare (Group) Co., Ltd.Humanwell Healthcare (Group) Co., Ltd.
17 Apr 2019
ALK positive Non-Small Cell Lung CancerPhase 1
China
Hubei Bio-Pharmaceutical Industrial Technological InstituteHubei Bio-Pharmaceutical Industrial Technological Institute
13 Sep 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free